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Introduction
Microscopic polyangitiis is characterized by anti-neu-
trophil cytoplasmic antibodies (ANCA) and small vessel
vasculitis. The diseases usually respond to cyclophospha-
mide (Cyc) but some patients are therapy resistant. Ritux-
imab (RIT) is a chimeric antibody to CD20 causing lysis
of B-lymphocytes and used for treatment of lymphomas.
RIT has also been successfully used in patients with rheu-
matoid arthritis (RA), idiopathic thromobocytopaenic
purpura, autoimmune haemolytic anaemia, cold aggluti-
nin disease, systemic lupus erythematosus and vascu-
litides.
Case report
A 16-year old female patient with hemoptysis, nephritis,
dermatitis was diagnosed as a myeloperoxidase-ANCA-
positive microscopic polyangiitis. The patient was resist-
ant to conventional therapy or had relapsed repeatedly
after cessation of cyclophosphamide (Cyc). The patient
was treated with intravenous infusions of rituximab (RIT).
Conclusion
RIT seems promising and safe in pediatric microscopic
polyangiitis. Controlled studies should be conducted.
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